Navigating the challenges of developing delivery devices for cell and gene therapy products in Europe

An article authored by Dr Patrick Ginty, Senior Director of Regulatory Affairs at Boyds, and Eamonn McGowran, Associate Director of Regulatory Affairs, has been published in Cell & Gene Therapy Insights’ August 2024 ‘Spotlight On’ innovation in cellular immunotherapy.